Outlook Therapeutics (OTLK) Leases (2016 - 2025)
Outlook Therapeutics (OTLK) has disclosed Leases for 8 consecutive years, with $212413.0 as the latest value for Q4 2025.
- Quarterly Leases fell 19.18% to $212413.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $212413.0 through Dec 2025, down 19.18% year-over-year, with the annual reading at $225508.0 for FY2025, N/A changed from the prior year.
- Leases for Q4 2025 was $212413.0 at Outlook Therapeutics, down from $225508.0 in the prior quarter.
- The five-year high for Leases was $262822.0 in Q4 2024, with the low at $212413.0 in Q4 2025.